Multivalent avb3 and metastasis-associated receptor ligands
CA 2338283 A1 · Owner: Fok, Kam F. · Inventors: Fok, Kam F.; Tjoeng, Foe S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to pharmaceutical compounds which are multivalent avb3 receptor/metastasis-associated receptor ligands. The use of these multivalent ligands alone or in conjunction with other agents in pharmaceutical compositions, and in methods for treating conditions mediated by avb3 for the treatment of cancer and other angiogenic diseases such as , diabetic retinopathy, arthritis hemangiomas, and psoriasis, are also , disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 7, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 7, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 7, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.